Teva Pharmaceutical Industries (TEVA) Times Interest Earned (2009 - 2025)
Teva Pharmaceutical Industries (TEVA) posted quarterly Times Interest Earned of $0.13 for Q4 2025, up 990.93% year-on-year from $0.01 in Q4 2024, and up 990.93% on a QoQ basis from -$0.01 in Q4 2024.
Teva Pharmaceutical Industries (TEVA) Times Interest Earned (2009 - 2025) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has reported Times Interest Earned for 16 consecutive years, with $0.13 the latest figure, recorded in Q4 2025.
- Quarterly Times Interest Earned rose 990.93% year-over-year to $0.13 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $0.92 (up 712.81% YoY) and the FY2025 annual result came in at $0.92, up 713.09% from the prior year.
- Times Interest Earned advanced to $0.13 in Q4 2025 per TEVA's latest filing, from -$0.01 in the prior quarter.
- Over the last five years, Times Interest Earned for TEVA reached as high as $0.25 in Q4 2023 and fell as low as -$0.31 in Q4 2022.
- A 5-year average of $0.02 and a median of $0.03 in 2021 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2022 — Times Interest Earned sank 1168.22% — and 2025, when it jumped 990.93%.
- Year by year, Times Interest Earned stood at $0.03 in 2021, then plunged by 1168.22% to -$0.31 in 2022, then surged by 182.11% to $0.25 in 2023, then tumbled by 105.72% to -$0.01 in 2024, then soared by 990.93% to $0.13 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered $0.13, -$0.01, and $0.25 for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.13 |
| Dec 31, 2024 | -0.01 |
| Dec 31, 2023 | 0.25 |
| Dec 31, 2022 | -0.31 |
| Dec 31, 2021 | 0.03 |
| Dec 31, 2020 | 0.16 |
| Dec 31, 2019 | 0.21 |
| Sep 30, 2019 | -0.13 |
| Jun 30, 2019 | -0.90 |
| Mar 31, 2019 | 0.19 |
| Dec 31, 2018 | -3.50 |
| Dec 31, 2017 | -1,759.05 |
| Dec 31, 2015 | 2.31 |
| Dec 31, 2014 | 3.02 |
| Dec 31, 2013 | 4.79 |
| Dec 31, 2012 | 3.33 |
| Dec 31, 2011 | 20.51 |
| Dec 31, 2010 | 0.98 |
| Dec 31, 2009 | 0.57 |